India met its 2020 malaria reduction target ahead of the global average. Critically examine the factors behind this success and challenges to achieving zero indigenous transmission by 2027.

While WHO projected that the world would miss the Global Technical Strategy (GTS) 2020 milestone of a 40% cut in case incidence [1], India was the only high-endemic country to record a 17.6% decline in 2019 over 2018 [2]. Cases fell 80.5% and deaths 78.3% between 2015 and 2023 [3] — a genuine gain, but one whose last mile remains the hardest.

Factors behind the success

• Strategic architecture: the National Framework for Malaria Elimination (NFME) 2016-2030, aligned with WHO's GTS and operationalised through the National Strategic Plan 2017-22, made India the first country in the South-East Asia Region to adopt an SDG-3-linked elimination target [4].
• Targeted, data-driven control: a shift from blanket spraying to district-specific action, notably the Intensified Malaria Elimination Project-3 (IMEP-3) covering 159 high-burden districts across 12 states [3].
• Integrated vector management and case detection: LLIN distribution, entomological surveillance and digital monitoring, delivered through ASHA-based community outreach [3].
• Demonstrated results: over 122 districts reported zero indigenous cases, Ladakh, Lakshadweep and Puducherry entered Category 0, and India exited WHO's High Burden to High Impact group in 2024 [5].

Challenges to zero indigenous transmission by 2027

• Biological hurdles: Plasmodium vivax relapses from dormant liver hypnozoites, and asymptomatic carriers in forested tribal belts, sustain silent transmission reservoirs [5].
• Resistance: emerging insecticide resistance in vectors and drug resistance risks erode existing tools.
• Surveillance gaps: under-reporting by the private sector, and mobile migrant and cross-border populations, weaken the case-by-case tracking elimination demands.
• Federal asymmetry: elimination depends on uneven state and district health capacity, making progress geographically lopsided.

India's decline reflects sound framework design meeting focused district execution. Sustaining it requires per-case investigation, radical vivax treatment, and assured financing rather than campaign-mode effort. If elimination-phase surveillance is institutionalised in the remaining endemic districts, the 2027 milestone can credibly anchor India's delivery on SDG target 3.3.